Abstract
Recent advances in the treatment of peritoneal metastasis from gastric cancer
Highlights
Peritoneal metastasis (PM) from gastric cancer (GC) was once considered a lethal disease
Radical gastrectomy plus perioperative chemotherapy improved the survival of patients with intraperitoneal micro metastasis
Complete cytoreduction combined with perioperative chemotherapy may cure the patients with macroscopic PM
Summary
Peritoneal metastasis (PM) from gastric cancer (GC) was once considered a lethal disease. Yonemura Y, et al [8] and Glehen O, et al [9] reported that IPC/hyperthermic intraperitoneal chemoperfusion (HIPEC) combined with cytoreductive surgery (CRS) (but not IPC alone) significantly improved the survival of GC patients with PM. Some patients were cured by a combination of neoadjuvant IPC, CRS, HIPEC, and postoperative chemotherapy [10].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
